Tuesday, December 2, 2014

#PumaBiotech will delay its filing for #FDA approval by a year for its experimental drug for treatment of breast cancer. Stock price dropped by almost 24% because of the news

Puma Biotech will delay its filing for FDA approval by a year for its experimental drug for treatment of breast cancer. Stock Price dropped by almost 24% because of the news  
http://www.wikio.co.uk